Phenescaline:
705 · PE:
716
Parker, MA; Kurrasch, DM; Nichols, DE. The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands Bioorg. Med. Chem., 1 Jan 2008, 16 (8), 4661–4669. 296 kB. https://doi.org/10.1016/j.bmc.2008.02.033 #21
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.
3C-BZ · 4-Benzyloxy-3,5-dimethoxyamphetamine
25H-NBOMe · 2C-H-NBOMe · N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine · DMPEA-NBOMe
2,4-DMPEA-NBOMe · 24-NBOMe · 24H-NBOMe · N-(2-Methoxybenzyl)-2,4-dimethoxyphenethylamine
4-Benzyloxy-2,5-dimethoxyamphetamine · MBZM
3,5-DMPEA-NBOMe · 35H-NBOMe · N-(2-Methoxybenzyl)-3,5-dimethoxyphenethylamine
2,6-DMPEA-NBOMe · 26H-NBOMe · N-(2-Methoxybenzyl)-2,6-dimethoxyphenethylamine
25D-NBOH · 2C-D-NBOH · N-(2-Hydroxybenzyl)-4-methyl-2,5-dimethoxyphenethylamine
25H-NB3OMe · N-(3-Methoxybenzyl)-2,5-dimethoxyphenethylamine
25H-NB4OMe · N-(4-Methoxybenzyl)-2,5-dimethoxyphenethylamine
N-(Phenoxypropan-2-yl)-β,4-dihydroxyamphetamine · N-PhOiPr-β,4-DHA · Isoxsuprine
3,4-DMA-NBOH · N-(2-Hydroxybenzyl)-3,4-dimethoxyamphetamine
2C-MBM · 4-(3-Methoxybenzyl)-2,5-dimethoxyphenethylamine
34H-NBOMe · N-(2-Methoxybenzyl-3,4-dimethoxyphenethylamine
23H-NBOMe · N-(2-Methoxybenzyl)-2,3-dimethoxyphenethylamine